Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Yacov Fabricant"'
Autor:
Sara Shimoni, Meital Zikri, Dan Haberman, Shay Livschitz, Sagi Tshori, Yacov Fabricant, Valery Meledin, Gera Gandelman, Sorel Goland, Jacob George
Publikováno v:
ESC Heart Failure, Vol 8, Iss 6, Pp 4549-4561 (2021)
Abstract Aims The aim of this study was to examine the prevalence of amyloid transthyretin (ATTR) cardiac amyloidosis in patients 1–2 years after trans‐catheter aortic valve replacement (TAVR) and to assess their clinical and echocardiographic ou
Externí odkaz:
https://doaj.org/article/256f81bce3414a559fe179f201bf8c6e
Wild-type TTR amyloidosis among patients with unexplained heart failure and systolic LV dysfunction.
Autor:
Sorel Goland, Igor Volodarsky, Yacov Fabricant, Shay Livschitz, Sagi Tshori, Valeri Cuciuc, Liaz Zilberman, Irena Fugenfirov, Valeri Meledin, Sara Shimoni, Sagie Josfberg, Jacob George
Publikováno v:
PLoS ONE, Vol 16, Iss 7, p e0254104 (2021)
AimTransthyretin cardiac amyloidosis (ATTR-CA) is an increasingly recognized cause of heart failure (HF) with preserved left ventricular ejection fraction (LVEF), typically presenting as restrictive cardiomyopathy. The potential co-existence of ATTR-
Externí odkaz:
https://doaj.org/article/70ec845e9cab478ea1c7e82ef99c724a
Autor:
Meital Zikri, Valery Meledin, G Gandelman, Sara Shimoni, Yacov Fabricant, Sagi Tshori, Jacob George, Shay Livschitz, Dan Haberman, Sorel Goland
Publikováno v:
ESC Heart Failure
ESC Heart Failure, Vol 8, Iss 6, Pp 4549-4561 (2021)
ESC Heart Failure, Vol 8, Iss 6, Pp 4549-4561 (2021)
Aims The aim of this study was to examine the prevalence of amyloid transthyretin (ATTR) cardiac amyloidosis in patients 1–2 years after trans‐catheter aortic valve replacement (TAVR) and to assess their clinical and echocardiographic outcome and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af5fa02842fe29e98a84b5a73329742f
https://pubmed.ncbi.nlm.nih.gov/34704399
https://pubmed.ncbi.nlm.nih.gov/34704399
Autor:
Sorel Goland, Igor Voldarsky, Valeri Cuciuc, Yacov Fabricant, Maya Saban Rappaport, Sara Shimoni, Orly Edri, Michael Fassler, Sagi Tshori, Shay Lifshitz, Jacob George
Publikováno v:
European Heart Journal. 41:1260-1270
Aims Cardiac amyloidosis typically manifests as heart failure with preserved left ventricular function due to extracellular plaques comprising aggregated TTR. Despite recent success in halting disease progression with a TTR stabilizer and encouraging
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38f3477398e0c0007eba253a4e98e291
https://doi.org/10.1093/eurheartj/ehz695
https://doi.org/10.1093/eurheartj/ehz695
Autor:
Shay Livschitz, Valeri Cuciuc, Yacov Fabricant, Sara Shimoni, Liaz Zilberman, Valeri Meledin, Jacob George, Sorel Goland, Igor Volodarsky, Sagie Josfberg, Sagi Tshori, Irena Fugenfirov
Publikováno v:
PLoS ONE, Vol 16, Iss 7, p e0254104 (2021)
PLoS ONE
PLoS ONE
Aim Transthyretin cardiac amyloidosis (ATTR-CA) is an increasingly recognized cause of heart failure (HF) with preserved left ventricular ejection fraction (LVEF), typically presenting as restrictive cardiomyopathy. The potential co-existence of ATTR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc40137d680d6612a485203633b20298
https://doaj.org/article/70ec845e9cab478ea1c7e82ef99c724a
https://doaj.org/article/70ec845e9cab478ea1c7e82ef99c724a
Autor:
Sagi Tshori, Jacob George, Dan Haberman, G Gandelman, Sara Shimoni, I Voldarsky, V Meladin, Yacov Fabricant, M Zikry Deitch, Sorel Goland, Moshe Swissa, S Lifshitz
Publikováno v:
European Heart Journal. 40
Introduction Aortic Stenosis (AS) is the most common valvular heart disease in the Western world. Transcatheter aortic valve implantation (TAVI) is an alternative to surgical valve replacement in medium and high-risk patients. One of the most common
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::95338f21e2e3203d15fc46c48fb86db8
https://doi.org/10.1093/eurheartj/ehz748.0543
https://doi.org/10.1093/eurheartj/ehz748.0543
Autor:
Yacov Fabricant, Sara Shimoni, Dan Haberman, G Gandelman, Jacob George, I Voldarsky, S Lifshitz, M Zikry Deitch, Sagi Tshori, Sorel Goland, V Meladin
Publikováno v:
European Heart Journal. 40
Background Aortic Stenosis (AS) is the most common valvular heart disease in the Western world. Wild-type transthyretin amyloid (wtATTR) affects the heart, causing restrictive cardiomyopathy. Deposits can be found in up to 25% of individuals >85 year
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c145539789aafd1e96356ca8b9c0d2dc
https://doi.org/10.1093/eurheartj/ehz747.0507
https://doi.org/10.1093/eurheartj/ehz747.0507